首页 > 最新文献

NEJM Journal Watch最新文献

英文 中文
Time to Treatment and Outcomes in Basilar Artery Occlusion 基底动脉闭塞的治疗时间和结果
Pub Date : 2021-11-16 DOI: 10.1056/NEJM-JW.NA54250
S. Chaturvedi
Basilar artery occlusion (BAO) has long been recognized as an acute stroke syndrome with poor prognosis. Endovascular thrombectomy (EVT) has been
基底动脉闭塞(BAO)一直被认为是一种预后不良的急性脑卒中综合征。血管内取栓术(EVT)
{"title":"Time to Treatment and Outcomes in Basilar Artery Occlusion","authors":"S. Chaturvedi","doi":"10.1056/NEJM-JW.NA54250","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54250","url":null,"abstract":"Basilar artery occlusion (BAO) has long been recognized as an acute stroke syndrome with poor prognosis. Endovascular thrombectomy (EVT) has been","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85624572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Score for Acute Kidney Injury After Percutaneous Coronary Intervention 经皮冠状动脉介入治疗后急性肾损伤的风险评分
Pub Date : 2021-11-16 DOI: 10.1056/NEJM-JW.NA54312
H. Krumholz, Sm
Contrast-associated acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is a common complication that can increase the risk for
经皮冠状动脉介入治疗(PCI)后造影剂相关急性肾损伤(AKI)是一种常见的并发症,可增加心血管疾病的风险
{"title":"Risk Score for Acute Kidney Injury After Percutaneous Coronary Intervention","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54312","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54312","url":null,"abstract":"Contrast-associated acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is a common complication that can increase the risk for","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86007687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Certain Categories of Persons Living with HIV Have Worse COVID-19 Outcomes 某些类别的艾滋病毒感染者的COVID-19预后较差
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54275
K. Henry
Previous reports of the impact of HIV infection on COVID-19's clinical course have left uncertainty about the interactions between those two conditions
之前关于艾滋病毒感染对COVID-19临床过程影响的报告对这两种情况之间的相互作用留下了不确定性
{"title":"Certain Categories of Persons Living with HIV Have Worse COVID-19 Outcomes","authors":"K. Henry","doi":"10.1056/NEJM-JW.NA54275","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54275","url":null,"abstract":"Previous reports of the impact of HIV infection on COVID-19's clinical course have left uncertainty about the interactions between those two conditions","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89623439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Status Benefit with Empagliflozin in Heart Failure with Preserved Ejection Fraction 恩格列净对保留射血分数的心力衰竭患者的健康状况有益
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54311
H. Krumholz, Sm
The industry-funded EMPEROR-Preserved (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction;
行业资助的Empagliflozin在保留射血分数的慢性心力衰竭患者中的结局试验;
{"title":"Health Status Benefit with Empagliflozin in Heart Failure with Preserved Ejection Fraction","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54311","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54311","url":null,"abstract":"The industry-funded EMPEROR-Preserved (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction;","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75276098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining SGLT-2 Inhibitors and GLP-1–Receptor Agonists for CV Risk Reduction in Type 2 Diabetes 联合SGLT-2抑制剂和glp -1受体激动剂降低2型糖尿病心血管风险
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54310
H. Krumholz, Sm
There is much excitement about the emerging evidence on sodium–glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1)–receptor
关于钠-葡萄糖共转运蛋白-2 (SGLT-2)抑制剂和胰高血糖素样肽-1 (GLP-1)受体的新证据令人兴奋
{"title":"Combining SGLT-2 Inhibitors and GLP-1–Receptor Agonists for CV Risk Reduction in Type 2 Diabetes","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54310","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54310","url":null,"abstract":"There is much excitement about the emerging evidence on sodium–glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1)–receptor","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84362687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Announcing a Co-Editor-in-Chief of 宣布联合主编
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54319
H. Krumholz, Sm
Dear readers,I am so pleased to announce that Karol E. Watson, MD, PhD, FACC, an Associate Editor for NEJM Journal Watch Cardiology since 2015, will
亲爱的读者们,我很高兴地宣布,carol E. Watson,医学博士,FACC,自2015年以来担任NEJM Journal Watch Cardiology的副主编
{"title":"Announcing a Co-Editor-in-Chief of","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54319","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54319","url":null,"abstract":"Dear readers,I am so pleased to announce that Karol E. Watson, MD, PhD, FACC, an Associate Editor for NEJM Journal Watch Cardiology since 2015, will","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80772851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Annuloplasty for Moderate Regurgitation During Mitral-Valve Surgery: Clinical Benefit Still Unclear 二尖瓣手术中中度返流的三尖瓣成形术:临床效果尚不清楚
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54293
H. Herrmann
Many patients undergoing mitral-valve surgery have associated tricuspid regurgitation (TR). Whether repair with tricuspid annuloplasty (TA) improves
许多接受二尖瓣手术的患者伴有三尖瓣反流(TR)。三尖瓣环成形术(TA)修复是否改善
{"title":"Tricuspid Annuloplasty for Moderate Regurgitation During Mitral-Valve Surgery: Clinical Benefit Still Unclear","authors":"H. Herrmann","doi":"10.1056/NEJM-JW.NA54293","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54293","url":null,"abstract":"Many patients undergoing mitral-valve surgery have associated tricuspid regurgitation (TR). Whether repair with tricuspid annuloplasty (TA) improves","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72706669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction 血管紧张素受体-奈普利素抑制与急性心肌梗死的ACE抑制
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54253
H. Krumholz, Sm
Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in
血管紧张素受体- neprilysin抑制剂sacubitil - valsartan是否优于血管紧张素转换酶(ACE)抑制剂雷米普利
{"title":"Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54253","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54253","url":null,"abstract":"Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82865392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should We Perform Valve Replacement for Severe Asymptomatic Aortic Stenosis 严重无症状主动脉瓣狭窄是否应该进行瓣膜置换术
Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54307
D. Cohen
Aortic valve replacement is indicated for patients with severe symptomatic aortic stenosis to improve both symptoms and long-term prognosis. For
主动脉瓣置换术适用于严重症状性主动脉狭窄患者,以改善症状和长期预后。为
{"title":"Should We Perform Valve Replacement for Severe Asymptomatic Aortic Stenosis","authors":"D. Cohen","doi":"10.1056/NEJM-JW.NA54307","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54307","url":null,"abstract":"Aortic valve replacement is indicated for patients with severe symptomatic aortic stenosis to improve both symptoms and long-term prognosis. For","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79933780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Exercise After Breast Cancer Surgery Improves Outcomes 乳腺癌手术后早期运动改善预后
Pub Date : 2021-11-12 DOI: 10.1056/NEJM-JW.NA54290
H. Kuerer
Axillary lymph node dissection with or without comprehensive nodal irradiation causes arm and shoulder disability in breast cancer patients. With the
腋窝淋巴结清扫加或不加综合淋巴结照射可导致乳腺癌患者手臂和肩部残疾。与
{"title":"Early Exercise After Breast Cancer Surgery Improves Outcomes","authors":"H. Kuerer","doi":"10.1056/NEJM-JW.NA54290","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54290","url":null,"abstract":"Axillary lymph node dissection with or without comprehensive nodal irradiation causes arm and shoulder disability in breast cancer patients. With the","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83226975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
NEJM Journal Watch
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1